Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001140361-16-058361

Options or other derivatives

  • Chief Development Officer acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Symonds William T. · Chief Development Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2016-03-15 Grant or award : show line 1 in the form Executive Stock Option (Right to Buy) +25,000 25,000 D
Loading xslF345X03/doc1.xml…